Benjamin Toogood
Directeur/Bestuurslid bij KAROLINSKA DEVELOPMENT AB
Oorsprong van het eerstegraads netwerk van Benjamin Toogood
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 22 | |
| Public Company | Financial Conglomerates | 15 | |
Pharmathen International SA
 Pharmathen International SA Pharmaceuticals: MajorHealth Technology Pharmathen was founded in 1969 in Athens, as a private pharmaceutical company, and is focused on the development and marketing of pharmaceuticals, with a strong position in generics. With 3 state of the art research laboratories and 2 manufacturing units, Pharmathen is a completely vertically integrated company and its activities extend from the development of pharmaceutical products up to their distribution. The company's human resources works in the sectors of Research & Development (R&D), production and distribution of drugs to different countries worldwide. Now, Pharmathen's products are approved in all EU markets and distribution rights have been granted to the largest pharmaceutical companies in the world, particularly in Europe, the United States of America and Canada.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
PHion Therapeutics Ltd.
 PHion Therapeutics Ltd. BiotechnologyHealth Technology PHion Therapeutics Ltd. operates as a therapeutic vaccine development company. Its vaccine program focuses on viral infections as it evokes a strong interferon gamma response. The firm's technology are RAVA and RAVA-V. The company was founded by Helen McCarthy in 2017 and is headquartered in Belfast, the United Kingdom.
4
| Holding Company | Biotechnology | 4 |
Softhale NV
 Softhale NV Miscellaneous Commercial ServicesCommercial Services Softhale NV engages in manufacturing medical, clinical and pharmaceutical equipment. The company was founded by Jurgen Rawert and Frank Bartels and is headquartered in Diepenbeek, Belgium.
4
| Subsidiary | Miscellaneous Commercial Services | 4 |
invoX Pharma Ltd.
 invoX Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., invoX Pharma Ltd. is a British biopharmaceutical company. The company is based in Kingston-upon-Thames, UK. The company was founded in 2021. Benjamin Toogood has been the CEO of the company since 2023.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Benjamin Toogood via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| Chia Tai-Tianqing Pharmaceutical Holdings Co., Ltd. | Director/Board Member Director/Board Member Corporate Officer/Principal President Director/Board Member | ||
Pharmathen SA
 Pharmathen SA Pharmaceuticals: MajorHealth Technology Pharmathen SA develops, manufactures, and markets pharmaceuticals. Its products include a-cnotren, adicanil, alcinin, atostana, aurid, azapin, belifax, calci-10, deprevix cr, esmocard, farbovil, faxiven, depilonine pro, depilonine cream, aripiprazole, atorvastatin, brinzolamide, caspofungin, and clopidogrel. The company was founded in 1969 and is headquartered in Pallini, Greece. | Pharmaceuticals: Major | President Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member Chief Executive Officer | |
Pharmathen Pharmaceuticals SA
 Pharmathen Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Pharmathen Pharmaceuticals SA develops and markets health care products. It manufactures cosmetics and pharmaceutical products and licenses out to the pharmaceutical companies in Europe, Canada, Australia, South Africa and the United States. The firm also distributes products in Africa, Asia, Latin America and the Middle East through a network of agents and distributors. The company was founded by Nicolas Katsos in 1969 and is headquartered in Pallini, Greece. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member Director/Board Member | |
Beijing Tide Pharmaceutical Co., Ltd.
 Beijing Tide Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Beijing Tide Pharmaceutical Co., Ltd. engages in research, development, manufacturing and sale of pharmaceutical products. The firm's products include kaifen flurbiprofen axetil injection, kaishi alprostadil injection, kaina beraprost sodium tablet and deyou pronase granules. The company was founded in May 1995 and is headquartered in Beijing, China. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member | |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The company was founded in 1969, and the CEO is Kang Xin Yu. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member Chairman | |
| Chia Tai Shaoyang Orthopedic Hospital | Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member | ||
Cp Pharmaceutical Qingdao Co. Ltd.
 Cp Pharmaceutical Qingdao Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Cp Pharmaceutical Qingdao Co. Ltd. is a private company that engages in the research and development, production, and sale of osteoporosis medicines and marine pharmaceuticals. Cp Pharmaceutical Qingdao Co. Ltd. is based in Qingdao, China. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member | |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Chief Executive Officer Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Chief Executive Officer Chief Executive Officer Director of Finance/CFO | |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Director/Board Member Director/Board Member Corporate Officer/Principal | ||
AnaCardio AB
 AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| National & Kapodistrian University of Athens | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Lund | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
Svenska Vaccinfabriken Produktion AB
 Svenska Vaccinfabriken Produktion AB BiotechnologyHealth Technology Svenska Vaccinfabriken Produktion AB develops vaccines and immunotherapies to prevent and treat life-threatening diseases. The company is based in Stockholm, Sweden. The Swedish company was founded by Matti Sällberg, Margaret Chen, Jens Bäck, Lars Frelin. Richard Bethell has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member | |
Umecrine Cognition AB
 Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member Director of Finance/CFO | |
Hong Kong Institute of Certified Public Accountants
 Hong Kong Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Hong Kong Institute of Certified Public Accountants operates under the professional accountant’s ordinance and works in the public interest. It offers CPA qualification programme and promulgating financial reporting, auditing and ethical standards in Hong Kong. The company was founded on January 1, 1973 and is headquartered in Hong Kong. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| SCIBASE HOLDING AB (PUBL) | Medical Specialties | Director/Board Member Director/Board Member | |
Pharmathen Holding 1 Ltd.
 Pharmathen Holding 1 Ltd. Financial ConglomeratesFinance Pharmathen Holding 1 Ltd. provides investment services. The private company is based in Saint Helier, UK. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| Stockholm School of Economics | College/University | Undergraduate Degree Masters Business Admin | |
| CP Boai Investment Ltd. | Director/Board Member Director/Board Member | ||
| University of Hong Kong | College/University | Undergraduate Degree Undergraduate Degree | |
| Friends of Hong Kong Association Ltd. | Corporate Officer/Principal Chief Executive Officer | ||
| Chia Tai Yeheng Biotech (Shanghai) Co., Ltd. | Director/Board Member Director/Board Member | ||
Dilafor AB
 Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| MEDIVIR AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| OSSDSIGN AB | Medical Specialties | Director/Board Member Director/Board Member | |
| MODUS THERAPEUTICS HOLDING AB | Biotechnology | Chairman Chief Executive Officer | |
KDev Investments AB
 KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. | Biotechnology | Chairman Director/Board Member | |
| KD Incentive AB | Director/Board Member Director/Board Member | ||
| PROMIMIC AB | Medical Specialties | Corporate Officer/Principal Director/Board Member | |
KDev Oncology AB
 KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services KDev Oncology AB offers research and development of new cancer treatments. It provides know-how in the field of oncology. The company was founded by David Jern on July 14, 2005 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
VOC Diagnostics AB
 VOC Diagnostics AB Medical/Nursing ServicesHealth Services VOC Diagnostics AB is a cancer diagnostics firm focusing on detection of ovarian cancer as a first indication. The company was founded by György Horvath in 2017 and is headquartered in Solna, Sweden. | Medical/Nursing Services | Chairman Chief Executive Officer | |
Pharmathen Holding 4 Ltd.
 Pharmathen Holding 4 Ltd. Pharmaceuticals: MajorHealth Technology Pharmathen Holding 4 Ltd. is a holding British company that operates through its subsidiaries in the pharmaceutical industry. The private company is involved in the development and marketing of pharmaceutical products. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Pharmathen Global Ltd.
 Pharmathen Global Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Pharmathen Holding 4 Ltd., Pharmathen Global Ltd. provides management services. The company is based in Hertford, UK. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Pharmathen Holding 3 Ltd.
 Pharmathen Holding 3 Ltd. Financial ConglomeratesFinance Pharmathen Holding 3 Ltd. is a British investment company founded in 2015. The private company is based in Saint Helier, UK. The company provides investment services. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Pharmathen Holding 2 Ltd.
 Pharmathen Holding 2 Ltd. Financial ConglomeratesFinance Pharmathen Holding 2 Ltd. is an investment holding British company founded in 2015. The private company is based in St. Helier, UK. The company's main function is to hold investments. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| University of Piraeus | College/University | Undergraduate Degree Undergraduate Degree | |
| Guanghua School of Management | College/University | Masters Business Admin Corporate Officer/Principal | |
| Scibase AB | Director/Board Member Director/Board Member | ||
| Nanjing Medical University | College/University | Doctorate Degree Doctorate Degree | |
| TIANJIN BINHAI TEDA LOGISTICS (GROUP) CORPORATION LIMITED | Air Freight/Couriers | Director/Board Member Director/Board Member | |
| Xian CP Pharmaceutical Co. Ltd. | Chairman Chief Executive Officer | ||
| CT Green Continent Pharmaceutical Technology Co. Ltd. | Director/Board Member Director/Board Member | ||
Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.
 Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. is a Chinese company that manufactures and distributes pharmaceutical products. The company is based in Dafeng, China. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Sino Biopharmaceutical (Beijing) Ltd.
 Sino Biopharmaceutical (Beijing) Ltd. Miscellaneous Commercial ServicesCommercial Services Sino Biopharmaceutical (Beijing) Ltd. is an investment holding company. Its sole asset is its 33.6% interest in Beijing Tide Pharmaceutical Co., Ltd., a pharmaceutical company established in China with limited liability, which develops, manufactures, and market pharmaceutical products. Sino Biopharmaceutical (Beijing) was founded on December 31, 2007 and is headquartered in Hong Kong. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Beijing Chia Tai Green Continent Pharmaceutical Co. Ltd.
 Beijing Chia Tai Green Continent Pharmaceutical Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Sino Biopharmaceutical Ltd., Beijing Chia Tai Green Continent Pharmaceutical Co. Ltd. researches and produces new pharmaceutical products. The company is based in Beijing, China. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
The University of Texas M.D. Anderson Cancer Center
 The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Other Consumer Services | Corporate Officer/Principal Corporate Officer/Principal | |
Qingdao Chia Tai Haier Pharmaceutical Co. Ltd.
 Qingdao Chia Tai Haier Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Qingdao Chia Tai Haier Pharmaceutical Co. Ltd. manufactures and sells pharmaceuticals. It is a subsidiary of Chia Tai Wing Fuk Ltd. It is headquartered in Qingdao, China | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Zweden | 20 |
| China | 15 |
| Hongkong | 7 |
| Verenigd Koninkrijk | 6 |
| Griekenland | 4 |
Sectoraal
| Health Technology | 18 |
| Consumer Services | 10 |
| Commercial Services | 8 |
| Finance | 5 |
| Health Services | 2 |
Operationeel
| Director/Board Member | 258 |
| Corporate Officer/Principal | 91 |
| Independent Dir/Board Member | 40 |
| Chairman | 32 |
| Chief Executive Officer | 30 |
Sterkste connecties
| Insiders | |
|---|---|
| Ping Tse | 43 |
| Viktor Drvota | 41 |
| Per Gunnar Ernst Aniansson | 31 |
| Zheng Fei Lu | 27 |
| Anna Lefevre Skjöldebrand | 17 |
| Kwok Tung Li | 17 |
| Cheung Ling Cheng | 15 |
| Hsin Tse | 15 |
| Greg Parekh | 14 |
| John Stephen Fox | 14 |
| Theresa Tse | 14 |
| Vassilios Katsos | 13 |
| Fredrik Järrsten | 12 |
| John Öhd | 11 |
| Thomas Andersson | 10 |
- Beurs
- Insiders
- Benjamin Toogood
- Bedrijfsconnecties